Why the common cold virus is a life-threatening predator for the very young and old.

Health · Published 30 September 2026 Swipe more like this →

In short: Respiratory syncytial virus is a master of immune evasion, infecting nearly every child before age two. While usually causing mild cold-like symptoms in healthy adults, this virus can turn deadly for infants and the elderly by triggering severe inflammation and obstructing the small airways of the lungs.

Discovered in 1956 within a chimpanzee population, the respiratory syncytial virus (RSV) is a highly contagious RNA virus that causes infections of the respiratory tract. Its name stems from the large, multinucleated cells called syncytia that form when the virus forces infected cells to fuse together. The virus is a significant global pathogen, circulating in two primary antigenic subtypes, A and B. Subtype A is generally considered more virulent, characterized by higher viral loads and faster transmission rates.

The virus spreads through contaminated droplets released during coughing or sneezing, and potentially through aerosols generated by routine breathing or talking. Once it enters the eyes or nasal passages, it targets the epithelial cells of the airways. In infants, the resulting inflammation and mucus production can lead to bronchiolitis, a condition where small airways become obstructed. Because infants have smaller airways than adults, they are particularly vulnerable to respiratory distress, which can manifest as rapid breathing, wheezing, and chest retractions.

RSV is notorious for its ability to reinfect individuals throughout their lives, largely because it interferes with the body's ability to establish long-term immunological memory. While healthy adults typically experience only mild symptoms, the virus poses a severe threat to the elderly and those with compromised immune systems, such as transplant recipients. In these vulnerable groups, RSV can lead to pneumonia and death. Researchers have identified that the virus employs a sophisticated arsenal of over 11 proteins to modulate the host immune response, effectively evading neutralization and complicating the development of lasting immunity.

Management of severe cases is primarily supportive, focusing on oxygen therapy and advanced breathing assistance. However, the landscape of prevention has shifted significantly with the 2023 approval of the first RSV vaccines for older adults and the use of monoclonal antibody treatments for high-risk infants. Despite these advances, the virus remains a persistent challenge, with its ability to mutate and evade immune detection continuing to drive seasonal outbreaks worldwide.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Why a common cold can become a serious respiratory struggle
• More than two hundred viruses can give you a cold
• Why the common cold is the ultimate master of human disruption and transmission
• The common cold is a complex viral landscape, not a single disease
• The common cold is a viral marathon, not a sprint
• In Rett syndrome, brain cells go quiet rather than die
• Medical residents are called that because they once lived in hospitals
• How a warning label nearly wiped out a deadly childhood brain disease
• How the Reserve Officers' Training Corps shapes the future of the American military
• When your muscles break down, they can poison your kidneys from the inside out.
• One to two billion people see the world slightly out of focus
• Rheumatoid arthritis is an immune attack that reaches far beyond joints

More in Health, medicine and disease · More in Health · Latest · A–Z · All topics